SKI Market

A+| A| A-|

Indian Indices

Sensex

77,844.52 -114.00
( -0.15%)

Global Indices

Nasdaq

49,922.52 603.26
(1.22%)

Dow Jones

7,387.39 107.17
(1.47%)

Hang Seng

62,916.52 3,403.40
(5.72%)

Nikkei 225

10,288.99 -149.67
(-1.43%)

Forex

USD-INR

95.18 0.09
(0.09%)

EUR-INR

111.29 -0.04
(-0.04%)

GBP-INR

128.89 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

461.79599

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

13.73

20600.32

EPS(TTM)

Face Value()

Div & Yield %

83.75

0.52

Back

Sakthi Sugars reports standalone net loss of Rs 34.20 crore in the December 2025 quarter

Feb 12,2026

Net Loss of Sakthi Sugars reported to Rs 34.20 crore in the quarter ended December 2025 as against net loss of Rs 23.04 crore during the previous quarter ended December 2024. Sales declined 9.58% to Rs 126.35 crore in the quarter ended December 2025 as against Rs 139.74 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	126.35	139.74	-10
OPM %	-8.44	-13.81	-
PBDT	-35.64	-46.73	24
PBT	-45.22	-56.07	19
NP	-34.20	-23.04	-48

77,844.52 -114.00 ( -0.15%)

49,922.52 603.26 (1.22%)

7,387.39 107.17 (1.47%)

62,916.52 3,403.40 (5.72%)

10,288.99 -149.67 (-1.43%)

95.18 0.09 (0.09%)

111.29 -0.04 (-0.04%)

128.89 -0.01 (-0.01%)

0.60 0.00 (-0.23%)